2021 Headache Medicine Reading List, Learning Objectives, and CME

Reading List

Please click below to access the 2021 Headache Medicine reading list.

2021 Headache Medicine Reading List »

C-cert Activity Description

The Continuous Certification (C-cert) activities provide subspecialty learning and knowledge assessment to ensure that diplomates are staying up to date on the latest science, treatments, and therapeutics relating to their subspecialty. The annual activities include: 1) reading the subspecialty  journal articles, and 2) taking and passing the 25-question online post-reading quiz to assess knowledge gained from the journal article content. 

Learning Objectives

Upon completion of this UCNS C-cert activity, participants will be able to:
  • Identify the criteria for neuroimaging in a patient who has a suspected diagnosis of migraine
  • Describe the clinical features of vestibular migraine
  • Discuss options for acute treatment of cluster headaches
  • Review options for preventive treatment of cluster headaches

Core Competencies

This UCNS C-cert activity covers the following core competency:
  • Medical Knowledge

Continuing Medical Education (CME) Instructions

To claim CME credits, answer question 26 on the quiz to reflect the total time spent completing the required reading and online quiz. This question is not included in the scoring of the quiz. A passing score of 80% of higher is needed to meet C-cert requirements and receive CME credit. CME credit confirmation will be emailed within three weeks of passing the quiz.

ACCME Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Academy of Neurology Institute (AANI) and United Council for Neurologic Subspecialties. The AANI is accredited by the ACCME to provide continuing medical education for physicians.

AMA Credit Designation Statement

The American Academy of Neurology Institute designates this enduring material for a maximum of 11 AMA PRA Category 1TM credit(s). Physicians should claim only their credit commensurate with the extent of the participation in the activity.

ABPN Self-Assessment Designation Statement

The American Board of Psychiatry & Neurology (ABPN) has reviewed the UCNS Continuous Certification (C-cert) self-assessment activity and has approved the program as a part of a comprehensive self-assessment (SA) program, which is mandates by the American Board of Medical Specialties as a necessary component of maintenance of certification. The number of ABPN SA credits granted will equal the number of CME hours claimed for the activity. 


The UCNS complies with all standards and policies of the ACCME, including identification and resolution of all conflicts of interest prior to the educational activity being delivered to learners. Accordingly, UCNS  planners, authors, and staff comply with the UCNS’s Conflicts of Interest Policy

2021 C-cert Activity Planner Disclosures
All relevant financial relationships have been mitigated.

Headache Medicine Certification Examination Committee Contributors

Jerry W. Swanson, MD, Chair, Mayo Clinic – Rochester
Disclosures: Receives royalty payments from UpToDate for editorial services. 

Robert Kaniecki, MD, Vice Chair, University of Pittsburgh Medical Center
Disclosures: Nothing to disclose.

Randolph W. Evans, MD, Houston Methodist
Disclosures: Receives speaker fees for being member of speaker's bureaus for Allergan, Amgen, Biohaven, Novartis, and Teva.

P. Christopher H. Gottschalk, MD, Yale Neurology Group
Disclosures: Amgen/Novartis: Consulting fees, Speaker Bureau Biohaven: SAB, Speaker Bureau Allergan (now AbbVie): Advisory Board, Speaker Bureau Lilly: Speaker Bureau Theranica: SAB Upsher-Smith: Consulting fees, SAB Axsome: SAB.

Christine Lay, MD, Women's College Hospital
Disclosures: Receives speaker's bureau fees from Aralez, Novartis; Member of advisory boards for Allergan, Lilly, Novartis, and Aralez. Fees are paid directly to the physician’s institution.

Christopher B. Oakley, MD, Johns Hopkins University – Department of Child Neurology
Disclosures: Nothing to disclose.

Lauren D. Strauss, DO, FAHS, Wake Forest Baptist Health
Disclosures: Nothing to disclose.

Stewart J. Tepper, MD, Dartmouth Hitchcock Medical Center
Disclosures: Receives honoraria as a Consultant and/or Advisory Board member for Acorda, Alder, Alexsa, Align Strategies, Allergan, Alphasights, Amgen, Aperture Venture Partners, Aralez Pharmaceuticals Canada, Axsome Therapeutics, Becker Pharmaceutical Consulting, BioDelivery Sciences International, Biohaven, Charleston Labs, Currax, Decision Resources, DeepBench, Dr. Reddy’s, ElectroCore, Eli Lilly, eNeura, Equinox, ExpertConnect, GLG, GSK, Guidepoint Global, Impel, M3 Global Research, Magellan Rx Management, Marcia Berenson Connected Research and Consulting, Medicxi, Navigant Consulting, Neurolief, Nordic BioTech, Novartis, Pfizer, Pulmatrix, Reckner Healthcare, Relevale, Revance, Satsuma, Scion Neurostim, Slingshot Insights, Sorrento, Spherix Global Insights, Sudler and Hennessey, Synapse Medical Communications, Teva, Theranica, Thought Leader Select, Trinity Partners, XOC, Zosano.


Staff Contact

Bryan Hagerla, Continuous Certification Manager
Disclosures: Nothing to disclose.
[email protected]
(612) 928-6326